In the media

<p>Valentina Maria Zinna, Salvador Aznar Benitah, Patrick Welz and Inés Marín Guillén, IRB Barcelona.</p>
31 May 2019 -

The newspapers La Vanguardia, Ara, and ABC, among other media, have echoed news of the publication of two studies in Cell by Salvador Aznar Benitah, ICREA researcher at IRB Barcelona, done in collaboration with the University of California, Irvine (USA). The research concludes that in mice with an impaired central clock, which is located in the brain, each tissue knows the time and is able to respond to changes in light that occur between the day and night.

Link to La Vanguardia

Link to...

<p>Clara Campàs, founding partner of Asabys Partners, Salvador Aznar-Benitah and Valerie Vanhooren, founders of Ona Therapeutics, and Sergio Pérez, director of Sabadell Venture Capital</p>
23 May 2019 -

La Vanguardia and Expansión Catalunya, among other media, have devoted an articleto Ona Therapeutics, the new IRB Barcelona spin-off that has completed a seed financing round of 1.5 million euros, invested entirely by Sabadell Asabys. With this injection of capital, the spin-off created by IRB Barcelona, ICREA and the researchers Salvador Aznar Benitah and Valerie Vanhooren, will start up activity with the development of a new drug for the treatment of metastatic cancer.

Link to La Vanguardia

Link to ...

<p>Antonio Zorzano and his team at the Complex Metabolic Diseases and Mitochondria Lab have participated in this study. IRB Barcelona.</p>
6 May 2019 -

La Vanguardia and La Sexta, among other media, have published an article on research headed by Antonio Zorzano, head of the Complex Metabolic Diseases and Mitochondria Lab at IRB Barcelona, which has identified a protein that protects against non-alcoholic fatty liver. “Mitofusin 2 emerges as a possible therapeutic target to combat fatty liver, a disease for which there is currently no treatment,” says the scientist.

The study has also been recommended by F1000 Prime.

Link to...

<p>Structure of EGFR. Purple indicates the region recognised by mAB806. Laura Orellana.</p>
3 May 2019 -

ABC has published an article on a study led by Modesto Orozco, head of the Molecular Modelling and Bioinformatics Lab at IRB Barcelona. This work has unravelled the mechanism of action of the mAb806 antibody, a drug used to treat glioblastoma. Published in the journal PNAS, the study lays the foundation for the extension of this treatment to more types of tumours and to more specific therapies.

Link to ABC

<p>Structure of the BasC transporter. </p>
24 Apr 2019 -

ABC and Gaceta Médica, among other media, have echoed on a study about the structure of a member of the L-amino acid transporter family (LAT), headed by IRB Barcelona researcher Manuel Palacín. “Knowing how LATs recognise the amino acids that they have to introduce into the cell allows us to better understand their function and helps us decipher the molecular defects associated with different pathologies and thus to develop potential treatments,” says Palacín.

Link to ABC

Link to Gaceta...

<p>Francesc Posas, director of IRB Barcelona, during his participation on TV3’s “Els Matins” programme.</p>
16 Apr 2019 - TV3

TV3’s programme “Els Matins” has interviewed Francesc Posas, director of IRB Barcelona, about the increase in donations given to NGOs and research centres in Catalonia and about the #Metastasis Challenge campaign. During the interview, he talked about the importance of small fundraising initiatives undertaken by individuals, such as that of Magdalena Socias, a cancer patient who has decided to join the challenge by walking the Sierra de Tramontana to give visibility to the fight against metastasis. Magdalena’s son, Adrià Cañellas, who is a PhD student at IRB Barcelona, also participated in the interview.

 

Link to...

<p>Magdalena Socias, cancer patient.</p>
9 Apr 2019 - ARA & other media

The radio station Cope, and the newspapers Ara Balear, Diario de Mallorca and Ultima Hora, among other media, have echoed news about the personal challenge taken on by Magdalena Socias, a cancer patient in Majorca, who intends to cross La Serra de Tramuntana on foot in order to increase awareness of the fight against the metastasis. This hike is part of the #MetastasisChallenge campaign, through which the Institute for Research in Biomedicine (IRB Barcelona) aims to raise €5 M over the next four years to boost research in this field. Magdalena will walk the 110 kilometers from Andratx to Pollença between 18 and 22 April. "I believe progress can be made through research. It is the best...

<p>Angel R. Nebreda, head of the Signalling and Cell Cycle Laboratory at IRB Barcelona</p>
25 Mar 2019 - La Opinión de Zamora

La Opinión de Zamora has published an article summarising the days of oncological research organised by the United Association against Cancer Toro and its Alfoz (AUCCTA) and in which Angel R. Nebreda, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) participated. During his talk, Nebreda commented: "We have come a long way but we still have a lot to do.But think about what we have achieved in the last 30 years, we know a lot more about how cancer develops and we have many more diagnostic methods, we know that there are hereditary cancers, that are genetic, and that they can be prevented by removing breasts and ovaries. We know that lung cancer is directly...

<p>Press conference at IRB Barcelona, presenting the #MetastasisChallenge</p>
19 Mar 2019 - Catalunya Ràdio & other media

Catalunya Ràdio, El Punt Avui, Expansión Catalunya, Europa Press, EFE, among other media, have published an article about the launch of the #MetastasisChallenge campaign. Through this initiative, the Institute for Research in Biomedicine (IRB Barcelona) calls society to action to support research into metastasis—the main cause of death from cancer—by raising €5 M over the next four years.

Link to El Punt Avui

Link to...

<p>Eduard Batlle in "Betevé Notícies Vespre"</p>
18 Mar 2019 -

Betevé Notícies Vespre has interviewed Eduard Batlle, coordinator to the Cancer Programme at the Institute for Research in Biomedicine (IRB Barcelona), about the recent campaign launched by the centre to raise funds for research into metastasis. “We have been studying metastasis at the centre for 10-12 years and have made some important findings. We now feel that it is a timely to push advances in this research, and with greater resources we will be able to speed up the process,” said Eduard Batlle.